VIM and non-small cell lung carcinoma: The value of amplified expression of vimentin is recognized as a prognostic marker is critical in non-small cell lung cancer (NSCLC) (Al-Saad et al., 2008; Dauphin et al., 2013; Ye et al., 2016; Teocharoen et al., 2021).